Editors' ChoiceCancer A new hope for neuroblastoma treatment? Joan MonteroInstitute for Bioengineering of Catalonia, Carrer de Baldiri Reixac, 10-12, 08028 Barcelona, Spain. Email: jmontero{at}ibecbarcelona.eu See allHide authors and affiliations Science Translational Medicine 18 Dec 2019:Vol. 11, Issue 523, eaaz9769DOI: 10.1126/scitranslmed.aaz9769 Joan Montero Institute for Bioengineering of Catalonia, Carrer de Baldiri Reixac, 10-12, 08028 Barcelona, Spain. Email: Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: jmontero@ibecbarcelona.eu Article Info & Metrics eLetters AbstractCombined ALK and PIM1 inhibition may treat high-risk neuroblastomas.Copyright © 2019, American Association for the Advancement of ScienceView Full Text
A new hope for neuroblastoma treatment? By Joan Montero Science Translational Medicine18 Dec 2019 Combined ALK and PIM1 inhibition may treat high-risk neuroblastomas.
A new hope for neuroblastoma treatment? By Joan Montero Science Translational Medicine18 Dec 2019 Combined ALK and PIM1 inhibition may treat high-risk neuroblastomas.